Study of Endocrine-Related Conditions and Physiology
NCT03867448 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-05-12
Summary
Background:
Endocrine disorders involve changes to glands that produce hormones. Hormones are released by these glands into the blood so they can direct the function of other tissues in the body. Researchers want to study people who may have endocrine disorders. They want to learn more about the conditions that affect endocrine glands.
Objective:
To study adults with a variety of endocrine disorders for research and physician education.
Eligibility:
Adults ages 18 and older who have an endocrine or metabolic-related disorder
Healthy volunteers 18 and older
Design:
Participants will be screened with a review of their medical records.
Participants will have a physical exam and medical history.
The length of the study and the schedule will vary by participant. Tests may include:
Blood and urine tests
Stool and saliva samples
Imaging studies: Participants will lie on a table while a machine takes pictures of the body. They may be injected with a substance to make their organs more visible in the pictures.
Tests of endocrine tissue function
Consultation with other specialists
Sleep study
Medical photographs
Participants may be treated for their endocrine disorder. This could include:
Surgery. If tissue is removed during surgery, it may be studied.
Radiation
Medicine
Participants may have genetic testing. This will be done with a small amount of blood, cells from a cheek swab, or saliva.
Sponsoring Institution: National Institute of Digestive, Diabetes and Kidney Disease
Conditions
- Endocrine Disease
Interventions
- DEVICE
-
Creation of side holes in catheters for adrenal vein sampling
one or two side-holes will be created by the interventional radiologist to facilitate adrenal vein sampling
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Principal Investigators
-
Lynnette K Nieman, M.D. · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-27
- Primary Completion
- 2036-01-01
- Completion
- 2036-01-01
Countries
- United States
Study Locations
More Related Trials
-
Incretin Physiology Associated With Steroid Hormone Treatment
NCT00713440 ·Status: COMPLETED ·Phase: NA
-
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741 ·Status: COMPLETED
-
Effect of Insulin on Endothelin-Dependent Vascular Tone in the Forearm Circulation
NCT00001624 ·Status: COMPLETED ·Phase: PHASE1
-
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
NCT06105931 ·Status: RECRUITING ·Phase: PHASE1
-
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
NCT01988545 ·Status: UNKNOWN ·Phase: NA
-
Sleep Apnea in Type 1 Diabetes
NCT01935765 ·Status: COMPLETED ·Phase: NA
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes
NCT03582956 ·Status: TERMINATED ·Phase: NA
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
NCT01843855 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
NCT02077348 ·Status: COMPLETED ·Phase: NA
-
Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1
NCT03560323 ·Status: COMPLETED ·Phase: PHASE1
-
The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly
NCT00843479 ·Status: COMPLETED
-
Circulating Biomarkers in the Development of Type 1 Diabetes
NCT05505669 ·Status: RECRUITING
-
Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect
NCT00784745 ·Status: COMPLETED ·Phase: NA
-
Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes
NCT01021865 ·Status: COMPLETED
-
Incretins and Metabolism
NCT01607944 ·Status: COMPLETED
-
Short Term Effect of Glucocorticoids on Brown Adipose Tissue Thermogenesis in Humans
NCT03269747 ·Status: COMPLETED ·Phase: PHASE4
-
Boosting the Secretion of GLP-2 and GLP-1 Intestinal Hormones by Nutrients
NCT01727583 ·Status: COMPLETED ·Phase: NA
-
Leptin to Treat Lipodystrophy
NCT00025883 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism
NCT04300049 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prevention of Metabolic Complications of Glucocorticoid Excess
NCT01319994 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Plasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarction
NCT03314844 ·Status: COMPLETED
-
Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
NCT00607646 ·Status: COMPLETED ·Phase: EARLY_PHASE1